Navigation Links
Nuvo Announces 2009 second quarter financial results
Date:8/7/2009

xpose patients to potentially serious systemic side effects such as gastrointestinal bleeding and cardiovascular risks, Nuvo's clinical trials suggest that some of these systemic side effects occur less frequently with topically applied Pennsaid. There are more than 27 million Americans suffering from osteoarthritis and the United States market for this condition is estimated at US$4 billion annually.

About Nuvo Research Inc.

Nuvo is focused on the research and development of drug products delivered to and through the skin using its topical and transdermal drug delivery technologies. Nuvo's lead product is Pennsaid, a topical NSAID used for the treatment of osteoarthritis of the knee. Nuvo intends to leverage its skin-penetrating technologies to create a portfolio of topical and transdermal products targeting a variety of indications.

Nuvo is a publicly traded, Canadian pharmaceutical company headquartered in Mississauga, Ontario, with manufacturing facilities in Varennes, Quebec and Wanzleben, Germany and a research and development center in San Diego, California. For more information, please visit www.nuvoresearch.com.

These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but caution that these assumptions regarding future events, many of which are beyond the control of the Company, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report, as well as in the Company's Annual Information Form for the year ended December 31, 2008. The Company disclaims a
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
2. NATB Announces Partnership With Ronald McDonald House Charities(R)
3. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
6. AMN Healthcare Announces Second Quarter 2009 Results
7. IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
8. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
9. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
10. Feline Pine Announces National Take Your Cat to the Vet Day August 22
11. MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel com...rence , San Clemente, Cal...ker of breakthrough medical apparel, today announc... display at Medica 2009, a leading international t...orf, Germany. Medelita inaugurates its men,s colle...
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understandin... 20 Dr. Jeremy Schmahma...ol and neurologist at the Massachusetts General Ho...ted his laboratory,s research on the new field of ...INDlink Foundation. ,, Dr. Schmahmann is an awa...
(Date:11/20/2009)... Senators and Congressmen in Co...Over their Health Care Vote , ...enators and congressmen running for re-election ne...ical guru Charlie Cook, may come to regret voting ... bill, according to a breaking Zogby International...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNe...s on a mission to redefine what it means to be "ha...al counselor with a specialty in family counseling... Forest University, Gladding says research shows t...s to sadness and even depression during the holida...
(Date:11/20/2009)... blood pressure readings in children with chronic ...even during doctor,s office visits increasing a c...to research from Johns Hopkins Children,s Center a...pears online in the Journal of American Society of...sure measurements obtained during regular doctor v...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...he tragic drug trial that left six volunteers seri...ines for drug testing.// Southampton University re...he drugs firm AstraZeneca in a technique called "m...rug trial. "We can monitor at a local level ...
...ulie Brown, from Livingston has accused the NHS of...t she was still pregnant after undergoing treatmen...own's St John's hospital had told her that the fet...ant. "A scan on Monday showed my baby was still in...
... path breaking study from the Journal of Political...t bearing on how the child shapes //up in adulthoo...tions on health programs that seek to make changes...purposes is that whereas heredity is immutable, co...
...esearchers from Mayo Clinic have reported improved...linum toxin (BOTOX?) early after// the occurrence ...ovement from wrinkling the wound site by paralyzin... the early healing phase with the injection improv...
...esearchers have found that people who practice Tra...ce. In a research conducted among 12 healthy //lo...ontrols, researchers found that the people practic...ontrols practiced Transcendental Meditation for 5 ...
...esearchers at the University of Pennsylvania Schoo...llpox virus and the manner with which it attaches/...s a topoisomerase has become a very important drug...Frederic D. Bushman, PhD, Professor of Microbiolog...
Other Medicine News:Health News:Personal Growth and Success Dependent on Prenatal Health 2Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 2Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 3Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 4Health News:Penn Researchers Throw Light on the Structure Of Smallpox Virus Protein 2
(Date:11/20/2009)...v. 20 The National Association of ...ed a new initiative in the war on methamphetamine.... multi-state electronic tracking program that enfo...) medicines containing pseudoephedrine in real-tim...is based on a system that was developed and tested...
(Date:11/20/2009).... 20 The Department of ...o members of priority groups that did not have pre...linics are being held statewide on Nov. 20-22. Fri... on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On...p.m. to 8 p.m. ,, Individuals in the recommend...
(Date:11/20/2009)... Reportlinker.com announces that a...talogue. ,, Pipettes & Pipettors - A Globa...ker.com/p0164373/Pipettes--Pipettors---A-Global-Ma...m_medium=pr&utm_campaign=prnewswire ,, Pi...rt of any research laboratory. Large-scale applica...
Breaking Medicine Technology:National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 1Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 2Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 4Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2HIVMA supports public plan option to ensure patients needs are met 48950 1HIVMA supports public plan option to ensure patients needs are met 48950 2
...Phase II Testing Certification with Edifecs CORE T...at are now required in X12 Version 5010 , , BELLE...t it will, together with its partners CAQH and Har... lessons learned from the CORE Phase II Certificat...ed 5010 Rules, in a presentation at the HIMSS09 In...
...ovo Nordisk today announced that the Endocrinologi...ited States Food and Drug Administration (FDA) has... liraglutide, a once-daily human GLP-1 analogue. ...ated to the risk profile of liraglutide. , , ...upported that appropriate evidence of cardiovascul...
Other Medicine Technology:Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3
...Drug Screen Tests are available in 14 configuratio...Designed using Microgenics Antibody Technology, th...point of care immunoassay targeted to detect MDMA ...cross-reactivity to any isomer of methamphetamine ...
...ite test! QuickScreen™ multi-panel dip cards...our choice of any conceivable combination of 9 dif...r total flexibility for your drug testing program....-in timer tells you when to read the results. Our ...
Insure
...tely 500,000 people die each year of colon cancer ...mprovements (high contrast berium enema, colonosco...e in the success rate of curative treatment for co... past two decades. The chances of successful treat...
Medicine Products: